1. Home
  2. XOMA vs AMCX Comparison

XOMA vs AMCX Comparison

Compare XOMA & AMCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XOMA
  • AMCX
  • Stock Information
  • Founded
  • XOMA 1981
  • AMCX 1980
  • Country
  • XOMA United States
  • AMCX United States
  • Employees
  • XOMA N/A
  • AMCX N/A
  • Industry
  • XOMA Biotechnology: Pharmaceutical Preparations
  • AMCX Cable & Other Pay Television Services
  • Sector
  • XOMA Health Care
  • AMCX Telecommunications
  • Exchange
  • XOMA Nasdaq
  • AMCX Nasdaq
  • Market Cap
  • XOMA 294.2M
  • AMCX 275.8M
  • IPO Year
  • XOMA N/A
  • AMCX 2011
  • Fundamental
  • Price
  • XOMA $24.99
  • AMCX $6.01
  • Analyst Decision
  • XOMA Strong Buy
  • AMCX Sell
  • Analyst Count
  • XOMA 2
  • AMCX 5
  • Target Price
  • XOMA $69.50
  • AMCX $7.00
  • AVG Volume (30 Days)
  • XOMA 18.4K
  • AMCX 425.5K
  • Earning Date
  • XOMA 05-20-2025
  • AMCX 05-09-2025
  • Dividend Yield
  • XOMA N/A
  • AMCX N/A
  • EPS Growth
  • XOMA N/A
  • AMCX N/A
  • EPS
  • XOMA N/A
  • AMCX N/A
  • Revenue
  • XOMA $28,487,000.00
  • AMCX $2,380,086,000.00
  • Revenue This Year
  • XOMA $17.89
  • AMCX N/A
  • Revenue Next Year
  • XOMA $34.58
  • AMCX N/A
  • P/E Ratio
  • XOMA N/A
  • AMCX N/A
  • Revenue Growth
  • XOMA 498.72
  • AMCX N/A
  • 52 Week Low
  • XOMA $18.35
  • AMCX $5.41
  • 52 Week High
  • XOMA $35.00
  • AMCX $18.58
  • Technical
  • Relative Strength Index (RSI)
  • XOMA 65.43
  • AMCX 44.82
  • Support Level
  • XOMA $22.91
  • AMCX $5.57
  • Resistance Level
  • XOMA $25.17
  • AMCX $6.72
  • Average True Range (ATR)
  • XOMA 1.09
  • AMCX 0.30
  • MACD
  • XOMA 0.11
  • AMCX 0.03
  • Stochastic Oscillator
  • XOMA 100.00
  • AMCX 53.91

About XOMA XOMA Corporation

XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes. Geographically, the company operates in Switzerland, United States, Asia Pacific, Europe and Others.

About AMCX AMC Networks Inc.

AMC Networks owns several linear pay-TV networks, including AMC, WE tv, BBC America, IFC, and SundanceTV. AMC, its most widely distributed network, reached 60 million pay-TV households in the US at the end of 2024. The firm also had nearly 12.5 million US streaming subscribers, with AMC+ as the flagship streaming platform. With both its linear networks and streaming offerings, the firm caters to specific niche audiences. Over the last 15 years, AMC has shifted its focus to original scripted programming from classic movies. It creates content through AMC Studios and also generates revenue from licensing content. Following an international divestiture at the end of 2023, domestic operations make up nearly 90% of total revenue.

Share on Social Networks: